Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Abbott Announces New Partnerships and Programs to Advance its Diversity in Clinical Trials Initiative
Friday, May 12, 2023Abbott NYSE ABT today announced a series of new programs within its multimilliondollar initiative to increase diversity in clinical trials and improve care among underrepresented populations The new additions to Abbotts Diversity in Clinical Trials i...
Angelini Pharma and JCR Pharmaceuticals announce global collaboration for the development and commercialization of novel biologic therapies in epilepsy
Friday, May 12, 2023Angelini Pharma part of the privately owned Angelini Industries and JCR Pharmaceuticals Co Ltd TSE JCR announced today that they entered into an exclusive global development and commercialization agreement for the development of novel biologic thera...
Nona Biosciences Announces Strategic Collaboration Agreement with PharmaEssentia Innovation Research Center
Friday, May 12, 2023Nona Biosciences a whollyowned subsidiary of HBM Holdings Limited committed to cuttingedge technology innovation and provider of integrated solutions from Idea to IND I to ITM announced today it has entered into a strategic collaboration agreement wi...
Amgen And Tscan Therapeutics Announce Collaboration To Identify Novel Targets In Crohns Disease
Thursday, May 11, 2023Amgen NASDAQAMGN and TScan Therapeutics Inc NASDAQTCRX today announced a multiyear collaboration that will use TScans proprietary target discovery platform TargetScan to identify the antigens recognized by T cells in patients with Crohns disease Unde...
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
Thursday, May 11, 2023Bayer and Bicycle Therapeutics plc NASDAQ BCYC a biotechnology company pioneering a new and differentiated class of therapeutics by utilizing proprietary bicyclic peptides technology Bicycle today announced that they have entered into a strategic col...
UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities
Thursday, May 11, 2023Ariceum Therapeutics Ariceum a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hardtotreat cancersand UCB EURONEXT BRUSSELS UCB a global biopharmaceutical company today announced an exclusive...
Junshi Biosciences Announces Collaboration with Dr. Reddy’s to Develop and Commercialize Toripalimab in 21 Countries
Wednesday, May 10, 2023Shanghai Junshi Biosciences Co Ltd Junshi Biosciences HKEX SSE announced a collaboration with Dr Reddys Laboratories Limited Dr Reddys to develop and commercialize toripalimab the antiPD monoclonal antibody in Latin America India South Africa and a...
Eisai Enters Into Joint Development Agreement With Blissbio For Antibody Drug Conjugate BB-1701
Wednesday, May 10, 2023Eisai Co Ltd Headquarters Tokyo CEO Haruo Naito Eisai announced today that it has entered into a joint development agreement with Bliss Biopharmaceutical Hangzhou Co Ltd Headquarters Zhejiang Province China BlissBio for BB an antibodydrug conjugate A...
BeiGene Receives New Approvals for BRUKINSA® (zanubrutinib) in China
Wednesday, May 10, 2023BASEL Switzerland BEIJING CAMBRIDGE MassBUSINESS WIRE BeiGene NASDAQ BGNE HKEX SSE a global biotechnology company today announced the China National Medical Products Administration NMPA approved four applications for BRUKINSA zanubrutinib the com...
Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera
Wednesday, May 10, 2023Gilead Sciences Inc Nasdaq GILD today announced the acquisition of all outstanding shares of XinThera a privately held biotech company in San Diego The acquisition complements Gileads existing clinical development priorities by adding additional pipe...
